Ishihara K, Hanyuda H, Nakabayashi N
Institute for Medical and Dental Engineering, Tokyo Medical and Dental University, Japan.
Biomaterials. 1995 Jul;16(11):873-9. doi: 10.1016/0142-9612(95)94150-j.
Surface modification of segmented polyurethanes (SPUs) was carried out using new blood compatible polymers having both phospholipid polar groups and urethane bonds in the side chains. The polymers were composed of 2-methacryloyloxyethyl phosphorylcholine (MPC), n-butyl methacrylate (BMA) and methacrylate with a urethane bond (MU). The MPC copolymers were soluble in ethanol. The SPU membranes were immersed in an ethanol solution of MPC copolymers and dried in vacuo for coating. The surface formed was completely covered with the MPC copolymer which was confirmed by X-ray photoelectron spectroscopic analysis. The polymer coatings were hardly detached in water, ethanol and 40% aqueous solution of ethanol compared with poly(MPC-co-BMA) which did not have the MU moieties. Therefore, the MU moieties had affinity for the SPU. The surface modification of the SPUs suppressed platelet adhesion effectively after contact with platelet-rich plasma for 180 min.
使用侧链同时具有磷脂极性基团和聚氨酯键的新型血液相容性聚合物对嵌段聚氨酯(SPU)进行表面改性。这些聚合物由2-甲基丙烯酰氧基乙基磷酰胆碱(MPC)、甲基丙烯酸正丁酯(BMA)和带有聚氨酯键的甲基丙烯酸酯(MU)组成。MPC共聚物可溶于乙醇。将SPU膜浸入MPC共聚物的乙醇溶液中,然后真空干燥以进行涂层。通过X射线光电子能谱分析证实,形成的表面完全被MPC共聚物覆盖。与不具有MU部分的聚(MPC-co-BMA)相比,聚合物涂层在水、乙醇和40%乙醇水溶液中几乎不会脱落。因此,MU部分对SPU具有亲和力。与富含血小板血浆接触180分钟后,SPU的表面改性有效地抑制了血小板粘附。